• 

• ‌Application of Synthetic Biology New Materials

  Synthetic biology new materials provide new possibilities for multiple fields such as medicine and tissue engineering. In the field of implantable medical devices, conducting process research and product development for these devices, and exploring the application potential of independently developed biological new materials aims to provide patients with implantable medical devices that offer superior biocompatibility, enhanced functionality and biomimicry, and can better adapt to tissue environments and facilitate tissue repair.

• 

• Biomaterial Molecular Design Platform

  In response to unmet clinical or market application needs, this platform leverages bioinformatics, protein engineering, enzyme engineering, molecular biology, and other advanced approaches to rationally design and modify existing biomaterials. This process enables conventional biomaterials to gain new functional properties, while engineering methods are employed to enhance their applicability and accessibility. Additionally, through fully rational design, entirely novel artificial biomaterial molecules can be created, facilitating the discovery of new functional biomaterials and expanding the application directions and fields of biomaterials.

• 

• Bioengineering Raw Material Preparation Platform

  The company has established a mature bioengineering material preparation platform, possessing deep technical expertise and extensive development experience in the two mainstream tools of microbial and mammalian cell systems. The platform is capable of independently completing the entire process, from initial design and small-scale process development to pilot-scale production, tailored to the specific application scenarios and technical requirements of different biomaterials. It enables the preparation of bio-based raw materials ranging from gram to kilogram scale, meeting the needs of small-scale development and clinical trials for functional biomaterials.

• 

• Nano-Bionic Tissue Engineering Platform

  The Nano-Bionic Tissue Engineering Platform integrates the company's technical capabilities in genetic engineering and material preparation to perform bionic design of tissue engineering repair materials from both compositional and structural perspectives. Based on raw materials produced through genetic recombination that match the composition of the target tissue, the platform analyzes tissue structures across multiple scales, with a focus on the nanoscale. Utilizing a variety of material preparation techniques, it achieves nano-bionic mimicry, thereby inducing and promoting cell spreading, migration, proliferation, and differentiation. This accelerates tissue repair and reconstruction, offering an optimal solution for tissue regeneration.

• 

• Biomaterial Product Development Platform

  The Biomaterial Product Development Platform is dedicated to the research, development, registration/filing, and production of four major series of specialty products, including implantable Class III medical devices, drug-device combinations, medical aesthetic products, and cosmetics, primarily based on recombinant proteins, polysaccharides, and composite materials. Leveraging departmental expertise in nano-bionic tissue engineering and innovative biomaterial application technologies—such as freeze-drying, wet spinning, and electrospinning—the platform conducts comprehensive development processes ranging from small-scale and pilot-scale research to registration testing, clinical trials, registration submissions, and production licensing. This enables the commercialization of the company's proprietary innovative biomaterials.